Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 386748, "name": "Biofil Chemicals", "stock_name": "Biofil Chemicals", "full_name": "Biofil Chemicals & Pharmaceuticals Ltd", "name_url": "stocks-analysis/biofil-chemicals", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "28.84", "chg": -1.14, "chgp": "-3.8%", "dir": -1, "prev_price": "29.98", "mcapval": "47.00 Cr", "mcap": "Micro Cap", "scripcode": 524396, "symbol": "BIOFILCHEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE829A01014", "curr_date": "Mar 23", "curr_time": "", "bse_nse_vol": "17.73 k", "exc_status": "Active", "traded_date": "Mar 23, 2026", "traded_date_str": "2026 03 23", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biofil-chemicals-386748-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-biofil-chemicals-pharmaceuticals-ltd-fallingrising-3908850", "imagepath": "", "date": "2026-03-24 01:29:33", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been on a downward trajectory, losing 6.3% over the past four consecutive trading sessions. On the day in question, it opened with a gap down of 2.57%, signalling immediate selling pressure from the outset. Intraday, the share price touched a low of ₹28.50, representing a 4.94% decline from the previous close, and traded predominantly near this lower price point as indicated by the weighted average price data. This suggests that sellers dominated the session, with limited buying interest to support the price.</p>\n<p>Biofil Chemicals is currently trading just 2.88% above its 52-week low of ₹28.01, underscoring the stock’s proximity to its lowest valuation in a year. This proximity to the annual low often acts as a psycholo..." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-strong-sell-3900100", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiofilChemicals_mojoScore_3900100.png", "date": "2026-03-19 10:10:49", "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-strong-sell-3873036", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiofilChemicals_mojoScore_3873036.png", "date": "2026-03-05 10:10:53", "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.28.01", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2801-3873186", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiofilChemicals_priceRelatedfactors_3873186.png", "date": "2026-03-05 09:48:50", "description": "Biofil Chemicals & Pharmaceuticals Ltd has touched a new 52-week low of Rs.28.01 today, marking a significant decline amid continued underperformance relative to its sector and benchmark indices. The stock has now recorded losses for three consecutive days, accumulating a negative return of 8.59% over this period." }, { "title": "Biofil Chemicals Declines 1.63% Amid Strong Sell Downgrade and Valuation Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-declines-163-amid-strong-sell-downgrade-and-valuation-shift-3849996", "imagepath": "", "date": "2026-02-21 17:10:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Feb:</strong> Stock opens at Rs.34.30 following downgrade announcement</p>\n <p><strong>17 Feb:</strong> MarketsMOJO downgrades Biofil Chemicals to Strong Sell</p>\n <p><strong>17 Feb:</strong> Valuation grade shifts from very attractive to attractive</p>\n <p><strong>20 Feb:</strong> Stock rebounds to Rs.34.95, closing the week with a 4.33% gain on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.35.53</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close..." }, { "title": "Biofil Chemicals & Pharmaceuticals Downgraded to Strong Sell Amidst Flat Financials and Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-downgraded-to-strong-sell-amidst-flat-financials-and-weak-fundamentals-3843776", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_mojoScore_3843776.png", "date": "2026-02-17 08:37:09", "description": "Biofil Chemicals & Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its financial performance, valuation metrics, quality indicators, and technical outlook. The downgrade reflects a combination of flat recent financial trends, deteriorating profitability measures, and a valuation profile that, while attractive, is overshadowed by weak fundamentals and underwhelming market returns." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shift Signals Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-valuation-shift-signals-renewed-price-attractiveness-3843262", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_valuationdot_3843262.png", "date": "2026-02-17 08:01:44", "description": "Biofil Chemicals & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite ongoing sector headwinds and a challenging market environment. This recalibration in price-to-earnings (P/E) and price-to-book value (P/BV) ratios offers investors a fresh perspective on the stock’s price attractiveness relative to its historical and peer benchmarks." }, { "title": "Are Biofil Chemicals & Pharmaceuticals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-biofil-chemicals-pharmaceuticals-ltd-latest-results-good-or-bad-3838268", "imagepath": "", "date": "2026-02-13 20:03:33", "description": "Biofil Chemicals & Pharmaceuticals Ltd's latest financial results for Q2 FY26 present a complex picture characterized by significant revenue growth juxtaposed with sharply declining profitability metrics. The company reported net sales of ₹13.54 crores, reflecting a substantial quarter-on-quarter growth of 110.58% from ₹6.43 crores in Q1 FY26. Year-on-year, this growth appears even more pronounced at 461.83%, compared to a low base of ₹2.41 crores in the same quarter of the previous year.\n\nHowever, the company's net profit for the quarter was just ₹0.08 crores, which represents a dramatic decline of 96.68% from the previous quarter's profit of ₹2.41 crores. This stark contrast raises concerns about the sustainability of the company's earnings, particularly as the operating margin, excluding other income, stood at a mere 0.89%, a modest improvement from 0.16% in Q1 FY26 but still indicative of weak operation..." }, { "title": "Biofil Chemicals & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3828888", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_upper_circuit_3828888.png", "date": "2026-02-09 15:00:09", "description": "Shares of Biofil Chemicals & Pharmaceuticals Ltd surged to hit the upper circuit limit on 9 Feb 2026, propelled by robust buying interest and a near 10% intraday gain. The stock’s performance outpaced its sector and benchmark indices, reflecting renewed investor confidence despite a recent downtrend." } ], "total": 168, "sid": "386748", "stock_news_url": "https://www.marketsmojo.com/news/biofil-chemicals-pharmaceuticals-386748" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "14-Feb-2026", "details": "Submission of Publication of Un-audited Financial Results for the quarter and nine months ended on 31st December 2025 in the newspaper pursuant to Regulation 47 of SEBI( Listing Obligation and Disclosure Requirement ) Regulations 2015", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 13Th February 2026", "datetime": "13-Feb-2026", "details": "Outcome of Board Meeting held on Friday 13th February 2026", "source": "BSE" }, { "caption": "Un-Audited Financial Results Of The Company For The Quarter And Nine Month Ended On 31St December 2025", "datetime": "13-Feb-2026", "details": "Un-Audited Financial Results of the Company for the quarter and nine month ended on 31st December 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

16 Feb: Stock opens at Rs.34.30 following downgrade announcement

17 Feb: MarketsMOJO downgrades Biofil Chemicals to Strong Sell

17 Feb: Valuation grade shifts from very attractive to attractive

20 Feb: Stock rebounds to Rs.34.95, closing the week with a 4.33% gain on the day

Week Open

Rs.35.53

Week Close...

Read full news article

Biofil Chemicals & Pharmaceuticals Downgraded to Strong Sell Amidst Flat Financials and Weak Fundamentals

2026-02-17 08:37:09

Biofil Chemicals & Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its financial performance, valuation metrics, quality indicators, and technical outlook. The downgrade reflects a combination of flat recent financial trends, deteriorating profitability measures, and a valuation profile that, while attractive, is overshadowed by weak fundamentals and underwhelming market returns.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shift Signals Renewed Price Attractiveness

2026-02-17 08:01:44

Biofil Chemicals & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite ongoing sector headwinds and a challenging market environment. This recalibration in price-to-earnings (P/E) and price-to-book value (P/BV) ratios offers investors a fresh perspective on the stock’s price attractiveness relative to its historical and peer benchmarks.

Read full news article

Are Biofil Chemicals & Pharmaceuticals Ltd latest results good or bad?

2026-02-13 20:03:33

Biofil Chemicals & Pharmaceuticals Ltd's latest financial results for Q2 FY26 present a complex picture characterized by significant revenue growth juxtaposed with sharply declining profitability metrics. The company reported net sales of ₹13.54 crores, reflecting a substantial quarter-on-quarter growth of 110.58% from ₹6.43 crores in Q1 FY26. Year-on-year, this growth appears even more pronounced at 461.83%, compared to a low base of ₹2.41 crores in the same quarter of the previous year. However, the company's net profit for the quarter was just ₹0.08 crores, which represents a dramatic decline of 96.68% from the previous quarter's profit of ₹2.41 crores. This stark contrast raises concerns about the sustainability of the company's earnings, particularly as the operating margin, excluding other income, stood at a mere 0.89%, a modest improvement from 0.16% in Q1 FY26 but still indicative of weak operation...

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-02-09 15:00:09

Shares of Biofil Chemicals & Pharmaceuticals Ltd surged to hit the upper circuit limit on 9 Feb 2026, propelled by robust buying interest and a near 10% intraday gain. The stock’s performance outpaced its sector and benchmark indices, reflecting renewed investor confidence despite a recent downtrend.

Read full news article